Department of Psychology, Faculty of Science, Memorial University, 232 Elizabeth Avenue, St. John's, Newfoundland, A1B 3X9, Canada.
Department of Cellular & Physiological Science, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Support Care Cancer. 2021 Nov;29(11):6183-6186. doi: 10.1007/s00520-021-06307-5. Epub 2021 May 22.
Fear of cancer recurrence (FCR) is a significant problem for individuals diagnosed with a variety of different cancers. To date, FCR has not been studied in males with breast cancer. The objective of this study was to examine the severity of FCR in males with breast cancer.
Males with breast cancer participated in an anonymous online survey and completed the Fear of Cancer Recurrence Inventory-Short Form scale (FCRI-SF). A frequency analysis was used to determine the percentage of participants that fell above or below the clinical cutoff for significant FCR. Regressions explored associations between FCR, age, cancer stage, time since diagnosis, and self-health rating.
Fifty-nine participants completed the FCRI-SF. The mean age of the sample was 63.5 and 93% reported their race as white. The mean FCR score was 23.9 and 61% reported clinically significant FCR. More than 80% of the sample experienced at least problematic levels of FCR. Increasing age was associated with decreased FCR.
Results of this study suggest that FCR is prevalent in men with breast cancer but larger studies with representative samples should be undertaken to better assess the prevalence of FCR in this population and compare it with other groups of patients. More attention is needed to understand the psychological distress experienced by men diagnosed and treated for breast cancer.
癌症复发恐惧(Fear of cancer recurrence,FCR)是诊断出患有各种不同癌症的个体的一个重大问题。迄今为止,尚未在男性乳腺癌患者中研究过 FCR。本研究的目的是检验男性乳腺癌患者中 FCR 的严重程度。
男性乳腺癌患者参与了一项匿名在线调查,并完成了癌症复发恐惧量表-短式版(Fear of Cancer Recurrence Inventory-Short Form scale,FCRI-SF)。频率分析用于确定 FCR 显著高于或低于临床临界值的参与者的百分比。回归分析探索了 FCR、年龄、癌症分期、诊断后时间和自我健康评估之间的关系。
59 名参与者完成了 FCRI-SF。样本的平均年龄为 63.5 岁,93%的参与者报告其种族为白人。平均 FCR 评分为 23.9,61%的参与者报告存在临床显著的 FCR。超过 80%的样本经历了至少存在问题的 FCR 水平。年龄的增加与 FCR 的减少有关。
本研究结果表明,男性乳腺癌患者中 FCR 较为普遍,但应进行更大规模的、具有代表性的研究,以更好地评估该人群中 FCR 的患病率,并与其他患者群体进行比较。需要更多关注以了解被诊断和治疗乳腺癌的男性所经历的心理困扰。